NO875378D0 - Fremgangsmaate for fremstilling av grannlocyttstimulerende faktor (polypeptidderivater). - Google Patents

Fremgangsmaate for fremstilling av grannlocyttstimulerende faktor (polypeptidderivater).

Info

Publication number: NO875378D0
Authority: NO; Norway
Prior art keywords: neglocyt; polypeptid; derivatives; procedure; preparation
Prior art date: 1986-12-23

Application number

NO875378A

Other languages

English (en)

Other versions

NO176799C (no

NO875378L (no

NO176799B (no

Inventor

Tetsuro Kuga

Yoshinori Komatsu

Hiromasa Miyaji

Mariyuki Sato

Masami Okabe

Makoto Morimoto

Seiga Itoh

Motoo Yamasaki

Yoshiharu Yokoo

Kazuo Yamaguchi

Original Assignee

Kyowa Hakko Kogyo Kk

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1986-12-23

Filing date

1987-12-22

Publication date

1987-12-22

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=17961392&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO875378(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1987-12-22 Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk

1987-12-22 Publication of NO875378D0 publication Critical patent/NO875378D0/no

1988-06-24 Publication of NO875378L publication Critical patent/NO875378L/no

1994-02-14 Priority to NO19940495A priority Critical patent/NO315003B1/no

1995-02-20 Publication of NO176799B publication Critical patent/NO176799B/no

1995-05-31 Publication of NO176799C publication Critical patent/NO176799C/no

Classifications

- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/24—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against cytokines, lymphokines or interferons
- C07K16/243—Colony Stimulating Factors
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/53—Colony-stimulating factor [CSF]
- C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Genetics & Genomics (AREA)
Engineering & Computer Science (AREA)
General Health & Medical Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Biomedical Technology (AREA)
Zoology (AREA)
Wood Science & Technology (AREA)
General Engineering & Computer Science (AREA)
Biotechnology (AREA)
Molecular Biology (AREA)
Medicinal Chemistry (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Immunology (AREA)
Pharmacology & Pharmacy (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Public Health (AREA)
Chemical Kinetics & Catalysis (AREA)
Animal Behavior & Ethology (AREA)
Veterinary Medicine (AREA)
Plant Pathology (AREA)
Physics & Mathematics (AREA)
Microbiology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Communicable Diseases (AREA)
Hematology (AREA)
Diabetes (AREA)
Oncology (AREA)
Toxicology (AREA)
Gastroenterology & Hepatology (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Peptides Or Proteins (AREA)

NO875378A 1986-12-23 1987-12-22 DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid NO176799C (no)

Priority Applications (1)

Application Number	Priority Date	Filing Date	Title
NO19940495A NO315003B1 (no)	1986-12-23	1994-02-14	Fremgangsmåte for fremstilling av polypeptid samt DNA-sekvens som koder fordette

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP30679986		1986-12-23

Publications (4)

Publication Number	Publication Date
NO875378D0 true NO875378D0 (no)	1987-12-22
NO875378L NO875378L (no)	1988-06-24
NO176799B NO176799B (no)	1995-02-20
NO176799C NO176799C (no)	1995-05-31

Family

ID=17961392

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO875378A NO176799C (no)	1986-12-23	1987-12-22	DNA som koder for et polypeptid, rekombinant plasmid som koder for og kan uttrykke et polypeptid og fremgangsmåte for fremstilling av dette polypeptid

Country Status (10)

Country	Link
EP (1)	EP0272703B2 (no)
JP (1)	JPH068317B2 (no)
KR (1)	KR960016560B1 (no)
CA (1)	CA1341522C (no)
DE (1)	DE3786767T3 (no)
DK (1)	DK174044B1 (no)
ES (1)	ES2059354T5 (no)
HK (1)	HK164195A (no)
NO (1)	NO176799C (no)
PT (1)	PT86465B (no)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5718893A (en) *	1984-04-15	1998-02-17	Foster; Preston F.	Use of G-CSF to reduce acute rejection
US5298603A (en) *	1985-12-21	1994-03-29	Hoechst Aktiengesellschaft	GM-CSF protein, its derivatives, the preparation of proteins of this type, and their use
GB9107846D0 (en) *	1990-04-30	1991-05-29	Ici Plc	Polypeptides
DE4014750A1 (de) *	1990-05-08	1991-11-14	Boehringer Mannheim Gmbh	Muteine des granulozyten-stimulierenden faktors (g-csf)
US5688768A (en) *	1991-02-19	1997-11-18	Cor Therapeutics, Inc.	Recombinant thrombin receptor and related pharmaceuticals
US7119182B1 (en)	1991-02-19	2006-10-10	The Regents Of The University Of California	Recombinant thrombin receptor and related pharmaceuticals
US5581476A (en)	1993-01-28	1996-12-03	Amgen Inc.	Computer-based methods and articles of manufacture for preparing G-CSF analogs
HU217872B (hu)	1994-02-23	2000-04-28	Kyowa Hakko Kogyo Co., Ltd.	Polipeptid alkalmazása vérlemezke termelődést elősegítő gyógyszer előállítására
US5536495A (en) *	1994-04-15	1996-07-16	Foster; Preston F.	Use of G-CSF to reduce acute rejection
US20030053982A1 (en)	1994-09-26	2003-03-20	Kinstler Olaf B.	N-terminally chemically modified protein compositions and methods
US5824784A (en)	1994-10-12	1998-10-20	Amgen Inc.	N-terminally chemically modified protein compositions and methods
US6100070A (en) *	1995-10-05	2000-08-08	G. D. Searle & Co.	G-CSF receptor agonists
US6245740B1 (en)	1998-12-23	2001-06-12	Amgen Inc.	Polyol:oil suspensions for the sustained release of proteins
DE19860801A1 (de) *	1998-12-30	2000-07-06	Rhein Biotech Proz & Prod Gmbh	Rekombinanter Wachstumsfaktor mit der biologischen Aktivität eines G-CSF (Granulocyte Colony Stimulating Factor)
US8435939B2 (en)	2000-09-05	2013-05-07	Biokine Therapeutics Ltd.	Polypeptide anti-HIV agent containing the same
JP2004524005A (ja)	2000-09-08	2004-08-12	マサチューセッツ　インスティテュート　オブ　テクノロジー	Ｇ−ｃｓｆアナログ組成物および方法
JP2004527243A (ja)	2001-02-06	2004-09-09	メルク　パテント　ゲゼルシャフト　ミット　ベシュレンクテル　ハフトング	低減された免疫原性を有する修飾された顆粒球コロニー刺激因子（ｇ−ｃｓｆ）
KR100899970B1 (ko)	2001-02-19	2009-05-28	메르크 파텐트 게엠베하	Ｔ-세포 에피토프의 동정 방법 및 감소된 면역원성을 갖는분자의 제조를 위한 용도
PL371781A1 (en)	2001-07-11	2005-06-27	Maxygen Holdings, Ltd.	G-csf conjugates
US7557195B2 (en)	2002-03-20	2009-07-07	Biopolymed, Inc.	Stoichiometric conjugates of biocompatible polymers at the unpaired cysteine residue of the wild-type G-CSF
ES2403932T3 (es)	2002-08-27	2013-05-22	Biokine Therapeutics Ltd.	Antagonista de CXCR4 y uso del mismo
US7695723B2 (en) *	2002-12-31	2010-04-13	Sygnis Bioscience Gmbh & Co. Kg	Methods of treating neurological conditions with hematopoietic growth factors
US7785601B2 (en) *	2002-12-31	2010-08-31	Sygnis Bioscience Gmbh & Co. Kg	Methods of treating neurological conditions with hematopoietic growth factors
CA2517310C (en)	2003-02-28	2015-11-24	Chugai Seiyaku Kabushiki Kaisha	Stabilized protein-containing formulations comprising a poloxamer
US7220407B2 (en)	2003-10-27	2007-05-22	Amgen Inc.	G-CSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
AU2005306894B2 (en)	2004-11-05	2011-11-24	Northwestern University	Use of SCF and G-CSF in the treatment of cerebral ischemia and neurological disorders
WO2006128460A2 (en)	2005-06-01	2006-12-07	Maxygen Holdings Ltd.	Pegylated g-csf polypeptides and methods of producing same
EP2942059A1 (en)	2006-12-21	2015-11-11	Biokine Therapeutics LTD.	4f-benzoyl-tn14003 for use in the treatment of multiple myeloma
WO2009023566A2 (en)	2007-08-09	2009-02-19	Genzyme Corporation	Method of treating autoimmune disease with mesenchymal stem cells
US8758761B2 (en)	2007-09-30	2014-06-24	University Of Florida Research Foundation, Inc.	Combination therapies for treating type 1 diabetes
US9155780B2 (en)	2009-02-11	2015-10-13	Yeda Research And Development Co. Ltd.	Short beta-defensin-derived peptides
CN102481332A (zh)	2009-06-14	2012-05-30	拜欧肯疗法有限公司	用于提高血小板水平的肽疗法
CA2787648C (en)	2010-01-19	2014-10-07	Hanmi Science Co., Ltd.	Liquid formulations for long-acting g-csf conjugate
NZ602255A (en)	2010-03-04	2014-04-30	Pfenex Inc	Method for producing soluble recombinant interferon protein without denaturing
EP2552949B1 (en)	2010-04-01	2016-08-17	Pfenex Inc.	Methods for g-csf production in a pseudomonas host cell
US9439942B2 (en)	2012-04-24	2016-09-13	Biokine Therapeutics Ltd.	Peptides and use thereof in the treatment of large cell lung cancer
AU2016291817A1 (en)	2015-07-16	2018-02-22	Biolinerx Ltd.	Compositions and methods for treating cancer
EP3419645B1 (en)	2016-02-23	2020-09-02	BioLineRx Ltd.	Method of selecting a treatment regimen in acute myeloid leukemia (aml)

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS4869987A (no)	1971-12-27	1973-09-22
JPS58110600A (ja)	1981-12-25	1983-07-01	Kyowa Hakko Kogyo Co Ltd	ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
JPS61227526A (ja) *	1984-07-25	1986-10-09	Chugai Pharmaceut Co Ltd	新規なコロニー刺激因子
EP0215126B1 (en) *	1985-02-08	1991-07-31	Chugai Seiyaku Kabushiki Kaisha	Human granulocyte colony stimulating factor
US4810643A (en)	1985-08-23	1989-03-07	Kirin- Amgen Inc.	Production of pluripotent granulocyte colony-stimulating factor
EP0220520B1 (en) *	1985-09-30	1991-09-18	Chugai Seiyaku Kabushiki Kaisha	Human granulocyte colony stimulating factor
EP0256843A1 (en)	1986-08-11	1988-02-24	Cetus Corporation	Expression of g-csf and muteins thereof and their use
JP2581110B2 (ja) *	1987-10-26	1997-02-12	いすゞ自動車株式会社	パティキュレートトラップの再燃焼装置

1987
- 1987-12-22 NO NO875378A patent/NO176799C/no not_active IP Right Cessation
- 1987-12-22 DK DK198706809A patent/DK174044B1/da not_active IP Right Cessation
- 1987-12-23 PT PT86465A patent/PT86465B/pt unknown
- 1987-12-23 KR KR1019870014791A patent/KR960016560B1/ko not_active Expired - Fee Related
- 1987-12-23 CA CA000555332A patent/CA1341522C/en not_active Expired - Lifetime
- 1987-12-23 JP JP62326384A patent/JPH068317B2/ja not_active Expired - Lifetime
- 1987-12-23 ES ES87119157T patent/ES2059354T5/es not_active Expired - Lifetime
- 1987-12-23 EP EP87119157A patent/EP0272703B2/en not_active Expired - Lifetime
- 1987-12-23 DE DE3786767T patent/DE3786767T3/de not_active Expired - Lifetime
1995
- 1995-10-19 HK HK164195A patent/HK164195A/en not_active IP Right Cessation

Also Published As

Publication number	Publication date
HK164195A (en)	1995-10-27
PT86465B (pt)	1990-11-20
EP0272703A1 (en)	1988-06-29
DK680987D0 (da)	1987-12-22
DK680987A (da)	1988-06-24
DE3786767T2 (de)	1994-01-13
EP0272703B1 (en)	1993-07-28
JPS63267292A (ja)	1988-11-04
DE3786767T3 (de)	1998-04-16
KR960016560B1 (ko)	1996-12-14
ES2059354T3 (es)	1994-11-16
NO176799C (no)	1995-05-31
KR880007734A (ko)	1988-08-29
EP0272703B2 (en)	1997-10-15
DE3786767D1 (de)	1993-09-02
CA1341522C (en)	2007-03-13
DK174044B1 (da)	2002-05-06
JPH068317B2 (ja)	1994-02-02
ES2059354T5 (es)	1998-03-16
NO875378L (no)	1988-06-24
NO176799B (no)	1995-02-20
PT86465A (en)	1988-01-01

Publication	Publication Date	Title
NO875378D0 (no)	1987-12-22	Fremgangsmaate for fremstilling av grannlocyttstimulerende faktor (polypeptidderivater).
NO872966D0 (no)	1987-07-16	Fremgangsmaate for fremstilling av granulocyttstimulerende preparater.
NO870579L (no)	1987-08-17	Fremgangsmaate for fremstilling av indolizin-derivater.
NO871266D0 (no)	1987-03-26	Fremgangsmaate for fremstilling av terapeutisk aktive kinazolin-derivater.
NO872682D0 (no)	1987-06-26	Fremgangsmaate for fremstilling av imidazopyridiner.
NO870526L (no)	1987-08-13	Fremgangsmaate for fremstilling av terapeutisk aktive dikloranilin-derivater.
NO874032L (no)	1988-03-28	Fremgangsmaate for fremstilling av terapeutisk aktive catecholderivater.
NO874467D0 (no)	1987-10-26	Fremgangsmaate for fremstilling av 3-pyrrolidinoler.
NO875488D0 (no)	1987-12-30	Fremgangsmaate for fremstilling av terapeutisk aktive alkansulfonanilid-derivater.
NO880910D0 (no)	1988-03-01	Fremgangsmaate for fremstilling av chromonderivater.
NO874268L (no)	1988-04-15	Fremgangsmaate for fremstilling av n-substituerte piperazinoner.
NO884900L (no)	1989-05-05	Fremgangsmaate for fremstilling av ginkolid-derivater.
NO873400D0 (no)	1987-08-13	Fremgangsmaate for fremstilling av sulfidfri alkalivaeske.
NO874199D0 (no)	1987-10-07	Fremgangsmaate for fremstilling av imidazo-pyridinonderivater.
NO168941C (no)	1992-04-29	Fremgangsmaate for fremstilling av mercaptoacylprolin.
NO880345L (no)	1988-01-27	Fremgangsmaate for fremstilling av alkyl-tert-butyletere.
NO871907D0 (no)	1987-05-07	Fremgangsmaate for fremstilling av terapeutisk aktive alkenamid-derivater.
NO883398D0 (no)	1988-08-01	Fremgangsmaate for fremstilling av benzoksazinderivater.
NO884100D0 (no)	1988-09-15	Fremgangsmaate for fremstilling av halogentiazolderivater.
NO874698D0 (no)	1987-11-11	Fremgangsmaate for fremstilling av 2-guanidinothiazolderivater.
NO873019D0 (no)	1987-07-20	Fremgangsmaate for fremstilling av tetrahydrobenzotiazolkinolin-derivater.
NO872683D0 (no)	1987-06-26	Fremgangsmaate for fremstilling av difenylazometinderivater
NO166361C (no)	1991-07-10	Fremgangsmaate for fremstilling av methyl-4-okso-5-tetradecynoat.
NO873452L (no)	1988-02-19	Fremgangsmaate for fremstilling av galeniske preparater.
NO882888D0 (no)	1988-06-29	Fremgangsmaate for fremstilling av heteroaromatiske derivater av adenosin.

Legal Events

Date	Code	Title	Description
2008-01-28	MK1K	Patent expired